Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

48.09
Delayed Data
As of Jan 13
 -1.45 / -2.93%
Today’s Change
19.59
Today|||52-Week Range
57.00
+0.54%
Year-to-Date
Is Biogen's Stock Ready to Heat Up After a Forgettable 2016?
Jan 13 / MotleyFool.com - Paid Partner Content
The 1 Biotech Stock I Want to Own in 2017
Jan 11 / MotleyFool.com - Paid Partner Content
Reliance Trust Co of Delaware Buys Bank of America Corporation, Allergan PLC, SPDR S&...
Jan 13 / GuruFocus News - Paid Partner Content
3 Big Reasons (and 8 Smaller Ones) to Buy Ionis Pharmaceuticals Stock
Jan 10 / MotleyFool.com - Paid Partner Content
Why Ionis Pharmaceuticals Shares Fell by 22.8% in 2016
Jan 12 / MotleyFool.com - Paid Partner Content
Ionis, Novartis Ink Deal to Focus on Cardiovascular Treatments
Jan 09 / Zacks.com - Paid Partner Content
Biotech Investors 'Spooked' After Trump's Comments, JMP's King Says
Jan 11 / TheStreet.com - Paid Partner Content
5 Slides Every Ionis Pharmaceuticals Inc Investor Needs to See
Jan 05 / MotleyFool.com - Paid Partner Content
Company News for January 11, 2017
Jan 11 / Zacks.com - Paid Partner Content
Ionis (IONS) Stock Up on Positive Type II Diabetes Drug Data
Jan 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close49.54
Today’s open49.51
Day’s range47.84 - 50.60
Volume1,713,943
Average volume (3 months)2,263,810
Market cap$5.8B
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-37.05%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book28.82

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-0.98-1.90%
UTHRUnited Therapeutics ...+3.15+2.14%
VRXValeant Pharmaceutic...-0.30-1.92%
OPKOPKO Health Inc-0.04-0.44%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts


Search for Jobs